FUS-MB induced BBB opening alone could lower the Aβ and tau burden, induce neurogenesis and neural plasticity and enhance cholinergic function, resulting in cognitive improvement in preclinical models of AD [15-22]. The gene discussed is MAPT; the disease is Alzheimer disease.